Detailed answers about JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED, including incorporation, status, business activity, and accounts information.
When was JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED founded?
JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED was officially incorporated on 28 August 2025 and is registered under company number 16678535. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED?
JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED do?
JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED operates in the following sector: 99999 - Dormant Company. This provides insight into the company's primary business activity and industry focus.
What is JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED's registered address?
The registered office address of JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED is 167-169 GREAT PORTLAND STREET, FIFTH FLOOR, LONDON, UNITED KINGDOM, W1W 5PF. This is the official address filed with Companies House for legal and statutory correspondence.
Is JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED financially stable?
Financial accounts for JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.